IGHE and COVID-19: Therefore, we assessed systemic cytokine and antibody abundancies to investigate the induction of Th2 and IgE antibody responses, especially against non‐seasonal common allergens in acute severe, convalescent mild COVID‐19 patients, and mRNA‐vaccinated individuals.